UnitedHealthcare Expands Multiple Genetic and Molecular Policies
UnitedHealthcare (UHC) Community Plan’s August policy update revised several medical policies to reflect phase 2 of the DEX® Z-Code requirement for...
1 min read
On Oct. 30, the American Hospital Association and other organizations, including the College of American Pathologists, sent a letter to U.S. House and Senate leadership urging them to pass the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act (S.2761/H.R. 5269).
The legislation would modernize the Clinical Laboratory Fee Schedule (CLFS) with current and comprehensive commercial market data, reduce administrative data collection and reporting burdens for clinical laboratories and the Centers for Medicare & Medicaid Services, and promote diagnostic innovation through Medicare payment stability. The organizations also note that passage of the RESULTS Act would prevent pending payment cuts of up to 15 percent for about 800 clinical laboratory services, set to begin on Jan. 1, 2026.
“The CLFS represents less than 1 percent of total Medicare spending, while clinical laboratory services inform 70 percent of clinical decision-making,” the organizations wrote. “Timely access to innovative clinical laboratory tests is critical to the prevention, early detection, therapy selection, and effective management of chronic and life-threatening diseases.”
Both versions of the bill were introduced on Sept. 10 and have been referred to relevant committees for further consideration.
Source:
CMS Launches IDR Gateway: What Providers Need to Know Before September 15
In late 2026, the Federal Independent Dispute Resolution (IDR) process will transition from single-use web forms to the new IDR Gateway, which will...
Organizations Representing Clinical Labs and Diagnostics Write in Support of Legislation to Improve Medicare LCD Process
A coalition of more than 30 stakeholder organizations has written to key lawmakers expressing their support for the Timely Access to Coverage...